Phase 1 Head and Neck Cancers Clinical Trials

3 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–3 of 3 trials

Recruiting

Phase 1

Dosing Study of Radiation Combined With Tislelizumab and Pamiparib in Patients With Previously Treated Head and Neck Cancer

Head and Neck CarcinomaHead and Neck CancerHead and Neck Squamous Cell Carcinoma+2 more

University of Chicago30 enrolled1 locationNCT05526924

Recruiting

Phase 1

Intratumoral Delivery of Viral Replicon (saRNA) Particles Expressing IL-12 in Head and Neck Cancer

Head and Neck CancerSolid TumorsHNSCC+3 more

VLP Therapeutics41 enrolled1 locationNCT06736379

Recruiting

Phase 1

SCG142 TCR-T Cells for Human Papillomavirus-Associated Carcinomas

Cervical CancerAnal CancerPenile Cancer+5 more

The Affiliated Hospital of Qingdao University18 enrolled1 locationNCT06544720